title: The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives.
abstract: Asthma and chronic obstructive pulmonary disease (COPD) represent the leading chronic respiratory diseases of interest in the word, owing to their high prevalence and burden on the health system. Care of these patients, undergoing frequent exacerbations, is a heavy burden on healthcare systems. In the last few years, large improvements in the management of asthma and COPD have been made, owing to new drugs and management strategies, and to the improvement of the nonpharmacologic treatment of COPD. There are still many unmet needs in the treatment of these diseases. In asthma, strategies to improve control should be implemented. There is a need to use more biomarkers to tailor treatment, in the assessment and choice of appropriate therapy, especially in severe patients. In COPD, there is growing evidence of individual differences in lung function decline rate and associated differences in appropriate management strategies. Early effective and prolonged bronchodilation can slow disease progression and reduce the frequency of exacerbations. New perspectives include the use of biologic drugs (anticytokine monoclonal antibodies) in selected categories of severe asthmatics, potential new inhibitors of chemokines and cytokines involved in the pathobiology of asthma and COPD, and a further improvement of current drugs and better implementation of management strategies, particularly in COPD patients.
authors.affiliation: Cardiothoracic Department, Pulmonary Unit, University Hospital of Pisa, Italy. n.ambrosino@ao-pisa.toscana.it
authors.forename: Nicolino
authors.initials: N
authors.lastname: Ambrosino
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Paggiaro
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D001688:Biological Products / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D001993:Bronchodilator Agents / Q000627:therapeutic use; D006801:Humans; D011237:Predictive Value of Tests; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D012138:Respiratory Therapy; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents; D001688:Biological Products; D015415:Biomarkers; D001993:Bronchodilator Agents